Taysha Gene Therapies | S-8:员工福利计划证券登记
Taysha Gene Therapies | 4:持股变动声明-高管 Nolan Sean P.
Taysha Gene Therapies | 4:持股变动声明-高管 Nagendran Sukumar
Taysha Gene Therapies | 4:持股变动声明-高管 Alam Kamran
Taysha Gene Therapies | EFFECT:其他
Taysha Gene Therapies | S-3:特定交易注册声明
Taysha Gene Therapies | SC 13G/A:超过5%持股股东披露文件(修正)-Venrock Healthcare Capital Partners III, L.P.(4.4%),VHCP Co-Investment Holdings III, LLC(4.4%)等
Taysha Gene Therapies | SC 13G/A:超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(9.99%),Peter Kolchinsky(9.99%)等
Taysha Gene Therapies | SC 13G:超过5%持股股东披露文件-Avoro Capital Advisors LLC(9.99%),Behzad Aghazadeh(9.99%)
Taysha Gene Therapies | 10-Q:2024财年三季报
Taysha Gene Therapies | 8-K:Taysha Gene Therapies公布2024年第三季度财务业绩并提供公司最新情况
Taysha Gene Therapies | SC 13G/A:超过5%持股股东披露文件(修正)-FMR LLC(9.113%),Abigail P. Johnson(9.113%)
Taysha Gene Therapies | SC 13G:超过5%持股股东披露文件-BlackRock, Inc.(6.6%)
Taysha Gene Therapies | SC 13G:超过5%持股股东披露文件-BlackRock, Inc.(6.6%)
Taysha Gene Therapies | 10-Q:2024财年二季报
Taysha Gene Therapies | 8-K:Taysha Gene Therapies公布2024年第二季度财务业绩并提供公司最新情况
Taysha Gene Therapies | 144:拟议出售证券
Taysha Gene Therapies | 144:拟议出售证券
Taysha Gene Therapies | 144:拟议出售证券
Taysha Gene Therapies | 4:持股变动声明-股东 Manning Paul B